12 Nothing in this article is medical advice or a recommendation for human use
The drug belongs to the class of glucagon-like peptide-1 (GLP-1) analogs
LegitScript expects to see problematic behavior including illicit compounding, especially from overseas manufacturers, and counterfeit versions of brand name drugs for sale
It targets GLP-1, GIP, and glucagon receptors all at once
[DOI] [PMC free article] [PubMed] [Google Scholar] 53.Cornaciu I, Boeszoermenyi A, Lindermuth H, Nagy HM, Cerk IK, Ebner C, et al
So when a drug goes under shortage, that essentially gives authority to these compounders to start producing them, you know, to fill in these access gaps